Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
18.10
-0.32 (-1.74%)
At close: Aug 14, 2026, 4:00 PM EDT
17.78
-0.32 (-1.77%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Sarepta Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9122,25511,6149,02111,3757,841
Market Cap Growth
-4.09%-80.58%28.75%-20.70%45.06%-41.72%
Enterprise Value
2,1862,66411,8318,67710,9077,420
Last Close Price
18.1021.52121.5996.43129.5890.05
PE Ratio
--49.37---
Forward PE
32.7090.1215.47---
PS Ratio
0.971.036.117.2612.1911.17
PB Ratio
1.251.987.6010.5029.558.45
P/TBV Ratio
1.282.037.7410.8730.148.58
PEG Ratio
-7.48----
EV/Sales Ratio
1.111.216.226.9811.6910.57
EV/EBITDA Ratio
--46.25---
EV/EBIT Ratio
--54.25---
Debt / Equity Ratio
0.700.910.871.614.201.23
Debt / EBITDA Ratio
7.07-3.70---
Net Debt / Equity Ratio
0.180.09-0.02-0.35-0.97-1.05
Net Debt / EBITDA Ratio
-15.62-0.16-0.101.330.752.41
Net Debt / FCF Ratio
3.35-0.320.070.521.042.03
Asset Turnover
0.570.600.530.390.300.23
Inventory Turnover
2.442.842.103.905.214.12
Quick Ratio
2.441.332.743.233.635.05
Current Ratio
4.422.324.203.954.135.75
Return on Equity (ROE)
-9.48%-53.47%19.71%-86.15%-107.16%-49.57%
Return on Assets (ROA)
-1.13%-11.24%3.77%-5.24%-10.68%-9.04%
Return on Invested Capital (ROIC)
-3.36%-47.96%19.06%-93.16%--
Return on Capital Employed (ROCE)
-2.30%-29.20%6.70%-10.30%-21.40%-16.50%
Earnings Yield
-7.15%-31.64%2.02%-5.94%-6.19%-5.34%
FCF Yield
4.28%-13.63%-2.95%-6.40%-3.13%-6.14%
Buyback Yield / Dilution
-7.36%7.19%-16.75%-5.53%-7.75%-4.24%
SEC Filings: 10-K · 10-Q